NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

Funding Opportunity PAR-21-224 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding